文章名稱引用次數

• Defining the relationship between COPD and CVD: what are the implications for clinical practice?29
• Role of immune-checkpoint inhibitors in lung cancer18
• Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness15
• Biomarkers in the diagnosis of pleural diseases: a 2018 update12
• Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience12
• Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience11
• Fatigue is highly prevalent in patients with COPD and correlates poorly with the degree of airflow limitation11
• How will telemedicine change clinical practice in chronic obstructive pulmonary disease?11
• Dabrafenib in combination with trametinib in the treatment of patients with BRAF V600-positive advanced or metastatic non-small cell lung cancer: clinical evidence and experience10
• The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy9